Luo Pengyu, Tang Yuna, Chen Nan, Liu Pei, Wang Jing, Fan Yuchen, Liu Huihui, Wang Kai
Department of Hepatology, Qilu Hospital of Shandong University, Wenhuaxi Road 107#, Jinan, 250012, Shandong, People's Republic of China.
Hepatology Institute of Shandong University, Jinan, 250012, Shandong, People's Republic of China.
Eur J Med Res. 2025 Apr 9;30(1):259. doi: 10.1186/s40001-025-02502-w.
Hepatitis B virus (HBV) infection is a global public health challenge that alters the immune microenvironment of the liver and drives disease progression by triggering chronic inflammation that leads to hepatic cell death through multiple programmed cell death (PCD) modalities. Due to the persistence of covalently closed circular DNA in hepatocytes, there is a lack of curative drugs that can completely eradicate HBV. Therefore, revealing how HBV infection leads to changes in the hepatic immune microenvironment, as well as searching for specific molecular targets, is crucial for controlling the onset and progression of chronic hepatitis B (CHB). In this study, we used the single sample gene set enrichment analysis and CIBERSORT algorithms to assess immune cell infiltration in the livers of CHB patients. With three advanced machine learning algorithms, random forest, least absolute shrinkage and selection operator, and selected support vector machine recursive feature elimination, we identified the PCD signature genes associated with CHB from the candidate genes. We further validated that ubiquitin-specific peptidase 21 could differentiate CHB patients with different natural courses by receiver operating characteristic analysis. These findings enhance our understanding of the mechanisms of HBV infection.
乙型肝炎病毒(HBV)感染是一项全球性的公共卫生挑战,它会改变肝脏的免疫微环境,并通过引发慢性炎症驱动疾病进展,这种慢性炎症会通过多种程序性细胞死亡(PCD)方式导致肝细胞死亡。由于共价闭合环状DNA在肝细胞中持续存在,缺乏能够完全根除HBV的治愈性药物。因此,揭示HBV感染如何导致肝脏免疫微环境变化以及寻找特定分子靶点,对于控制慢性乙型肝炎(CHB)的发病和进展至关重要。在本研究中,我们使用单样本基因集富集分析和CIBERSORT算法评估CHB患者肝脏中的免疫细胞浸润情况。通过随机森林、最小绝对收缩和选择算子以及选择支持向量机递归特征消除这三种先进的机器学习算法,我们从候选基因中鉴定出与CHB相关的PCD特征基因。我们进一步通过受试者工作特征分析验证了泛素特异性肽酶21能够区分不同自然病程的CHB患者。这些发现增强了我们对HBV感染机制的理解。